[Translation] A multi-center, open-label Phase I clinical study to evaluate the safety, tolerability, pharmacokinetics and efficacy of NB003 in patients with advanced malignancies
1.确定NB003的最大耐受剂量和II期推荐剂量;2.评价NB003的安全性和耐受性。3.探索NB003的抗肿瘤活性
[Translation] 1. Determine the maximum tolerated dose and phase II recommended dose of NB003; 2. Evaluate the safety and tolerability of NB003. 3. Explore the anti-tumor activity of NB003